We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Sorafenib or Crizotinib and Vemurafenib in Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01531361
Recruitment Status : Recruiting
First Posted : February 10, 2012
Last Update Posted : March 29, 2017
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : February 2019
  Estimated Study Completion Date : February 2019